RECHEM
Welcome to our website!|Hot Line: 86-21-51623867|E-mail: sales@rechemscience.com
Products Category
Contact Us
Tel: +86-21-51623867
  +86-15618786686
Email: sales@rechemscience.com
  info@rechemscience.com
QQ1: 1369748377
Skype: sales@rechemscience.com
Home > Products > Angiogenesis > Bcr-Abl
Cat.No. Product name Product Description
R10097 GNF-2 GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no a
R10181 AP24534; Ponatinib Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VE
R10496 Dasatinib;BMS-354825;BMS354825 Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src
R10503 Nilotinib; AMN-107 Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine m
R10917 Radotinib; IY-5511 Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w
R10997 GNF-7 GNF-7 is a potent type-II kinase Bcr-Abl inhibitor with IC50 of <5 nM, 61 nM,
R11633 GZD824 (Synonyms: HQP1351) GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(W
Page 1 / Total 1 FirstPrevNextLastGoto
<button id="kaaoj"><acronym id="kaaoj"></acronym></button>

<dd id="kaaoj"></dd>
<button id="kaaoj"></button>
      1. <progress id="kaaoj"></progress>
        <tbody id="kaaoj"><track id="kaaoj"></track></tbody>
        <em id="kaaoj"><tr id="kaaoj"></tr></em>